Back to Journals » Neuropsychiatric Disease and Treatment » Volume 9

Dalfampridine extended release tablets: 1 year of postmarketing safety experience in the US

Total article views   Abstract views HTML views PDF downloads Totals
10,755 Dovepress* 9,140 600+ 1,378 9,740
PubMed Central* 0 1,015 380 1,015
Totals 9,140 1,615 1,758 10,755
*Since 10 March 2013
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar